Genomic Valley Biotech Ltd - Stock Valuation and Financial Performance

BSE: 539206 | NSE: | Agriculture | Small Cap

Genomic Valley Share Price

34.71 -1.82 -4.98%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Genomic Valley

M-Cap below 100cr DeciZen not available

Genomic Valley Biotech stock performance -

mw4me loader
P/E Ratio (SA):
10.07
Market Cap:
10.6 Cr.
52-wk low:
20.7
52-wk high:
50.1

Is Genomic Valley Biotech Ltd an attractive stock to invest in?

1. Is Genomic Valley Biotech Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Genomic Valley Biotech Ltd is a below average quality company.

2. Is Genomic Valley Biotech Ltd undervalued or overvalued?

The key valuation ratios of Genomic Valley Biotech Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Genomic Valley Biotech Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Genomic Valley Biotech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Genomic Valley:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Genomic Valley Biotech Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 0.2%-0%-6.7%-0.7%0.4%4.1%6.5%-6.9%-6.1%26.1%-
Value Creation
Index
-1.0-1.0-1.5-1.1-1.0-0.7-0.5-1.5-1.40.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0.100.10.40.610.90.20.12.71
Sales YoY Gr.--66.7%266.7%300%34.1%67.8%-14.1%-75.3%-66.7%3,785.7%-
Adj EPS 0-0.1-1.5-0.10.10.80.9-1.8-12.73.5
YoY Gr.--900%NANANA985.7%23.7%-294.7%NANA-
BVPS (₹) 16.11614.914.714.815.616.514.79.411.611.8
Adj Net
Profit
00-0.5000.20.3-0.6-0.30.81
Cash Flow from Ops. 00.1-0.70.40.9-10.41.5-2.1-0.8-
Debt/CF from Ops. 225.88.2-1.12.20.9-1.43.4100-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 46%35.8%47.4%3785.7%
Adj EPS 86.5%108.1%42.7%NA
BVPS-3.6%-4.9%-11.3%22.6%
Share Price - - 13.7% 59.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
0.1-0.4-7.8-0.80.555.8-11.7-8.22629.6
Op. Profit
Mgn %
13.1-149.5-406.6-6.517.542.265.4-65.6-534.832.486.4
Net Profit
Mgn %
4.4-78.6-410.9-9.43.623.633.8-268.7-429.130.690.7
Debt to
Equity
0.20.20.20.20.20.30.30.300-
Working Cap
Days
10,52330,5318,8832,0981,3828291,1323,6838,5144301,857
Cash Conv.
Cycle
0002532405819314486770

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 29.60%

Sales growth is growing at healthy rate in last 3 years 47.36%

Net Profit is growing at healthy rate in last 3 years 42.67%

Sales growth is good in last 4 quarters at 15.45%

No data to display

Latest Financials - Genomic Valley Biotech Ltd.

Standalone Consolidated
TTM EPS (₹) 3.5 -
TTM Sales (₹ Cr.) 1.2 -
BVPS (₹.) 11.8 -
Reserves (₹ Cr.) 1 -
P/BV 2.95 -
PE 10.07 -
From the Market
52 Week Low / High (₹) 20.65 / 50.14
All Time Low / High (₹) 8.25 / 50.14
Market Cap (₹ Cr.) 10.6
Equity (₹ Cr.) 3.1
Face Value (₹) 10
Industry PE 22.6

Management X-Ray of Genomic Valley:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Genomic Valley

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales0.090.030.110.440.590.990.850.210.072.72
Operating Expenses 0.080.080.550.540.490.570.290.340.451.84
Manufacturing Costs000.130.010.010.110.050.020.070.01
Material Costs0.020.010.070.100.050.05-0.070.0801.58
Employee Cost 0.010.030.130.250.340.270.180.090.140.15
Other Costs 0.040.040.220.190.100.150.130.160.230.09
Operating Profit 0.01-0.05-0.44-0.100.100.420.55-0.14-0.380.88
Operating Profit Margin (%) 13.1%-149.0%-406.0%-23.2%17.0%42.2%65.4%-65.6%-534.0%32.4%
Other Income 0.010.070.160.080.010.010.0100.080.04
Interest 0.010.030.020000.180.180.040
Depreciation 00.010.050.040.080.190.180.190.080.01
Exceptional Items 00000.020000.42-0.26
Profit Before Tax 0.01-0.01-0.34-0.070.060.230.21-0.5000.65
Tax 00-0.0100.020-0.080.060.010
Profit After Tax 0-0.01-0.33-0.070.030.230.29-0.56-0.010.65
PAT Margin (%) 4.4%-27.8%-307.0%-15.5%5.7%23.6%33.8%-268.0%-13.2%23.8%
Adjusted EPS (₹)0.00.0-1.1-0.20.10.80.9-1.80.02.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 5.935.925.584.494.534.765.054.492.883.53
Share Capital 3.053.053.053.053.053.053.053.053.053.05
Reserves 2.872.862.531.441.471.711.991.43-0.180.47
Minority Interest0000000000
Debt0.750.750.750.750.751.481.481.5500
Long Term Debt0.750.750.750.750.751.481.481.5500
Short Term Debt0000000000
Trade Payables0000.010.0100.060.0400.61
Others Liabilities 0.600.790.720.761.390.931.351.540.920.28
Total Liabilities 7.287.467.066.026.677.187.947.613.804.42

Fixed Assets

Gross Block3.023.193.253.754.324.705.026.602.570.48
Accumulated Depreciation00.040.080.120.200.390.550.740.820.48
Net Fixed Assets3.023.153.183.634.124.314.475.861.750
CWIP 00000.380.490.490.4900
Investments 00.550.110000000
Inventories0000.070.030.120.12000
Trade Receivables00000.020.060.100.0602.22
Cash Equivalents 0.730.170.010.050.010.080.040.0100.04
Others Assets3.533.593.762.262.112.132.721.192.042.16
Total Assets 7.287.467.066.026.677.187.947.613.804.42

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 00.09-0.690.350.87-1.040.441.48-2.13-0.78
PBT 0.01-0.01-0.34-0.070.060.230.21-0.50-0.420.91
Adjustment -0.01-0.03-0.11-0.030.040.180.180.19-0.26-0.03
Changes in Working Capital 0.010.13-0.230.450.77-1.450.061.8-1.45-1.66
Tax Paid 0000000000
Cash Flow From Investing Activity 0.01-0.650.53-0.31-0.910.37-0.47-1.583.671.52
Capex 0-0.14-0.08-0.5000.36-0.48-1.5800
Net Investments 0-0.550.440.11-0.940005.351.48
Others 0.010.040.160.080.030.0100-1.680.04
Cash Flow From Financing Activity 000000.7300.07-1.55-0.70
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 000000.7300.07-1.55-0.70
Net Cash Flow 0.02-0.56-0.160.04-0.040.06-0.04-0.03-0.010.04
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)0.09-0.17-7.08-1.510.765.015.83-11.73-0.2520.24
ROCE (%)0.410.34-5.99-1.311.124.126.1-5.140.9320.35
Asset Turnover Ratio0.0100.020.070.090.140.110.030.010.66
PAT to CFO Conversion(x)NANN/AN/AN/A29-4.521.52N/AN/A-1.2
Working Capital Days
Receivable Days00001415351470297
Inventory Days00058322852000
Payable Days000197144-1832313,71670

Genomic Valley Biotech Ltd Stock News

Genomic Valley Biotech Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Genomic Valley on 28-Mar-2024 16:01 is ₹34.71.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Genomic Valley stood at ₹10.60.
The latest P/E ratio of Genomic Valley as of 28-Mar-2024 16:01 is 10.07.
The latest P/B ratio of Genomic Valley as of 28-Mar-2024 16:01 is 2.95.
The 52-week high of Genomic Valley is ₹50.14 and the 52-week low is ₹20.65.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Genomic Valley is ₹1.16 ( Cr.) .

About Genomic Valley Biotech Ltd

Genomic Valley Biotech Limited (GVBL) is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.

Currently, the company is engaged in providing consultancy in: a. High-Tech Cultivation through Environment Controlled Poly Houses, NFT & DFT etc; and b. Organic Farming --- Open Field Cultivation using Bio-Fertilizer. The company is also trading in agricultural and horticultural products.

Business area of the company 

The Company is providing consultancy in the Horticultural and Agricultural products. The company is also trading in Horticultural and Agricultural products.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.